This volume examines the musculoskeletal system a complex network of molecular signaling both within the bone and also among bone, muscle, and other organs, such as the intestine, brain, pancreas, adipose tissue, and pituitary gland. Owing to these complex pathways, there are many novel molecular targets for drug development to treat disorders that have been heretofore overlooked or neglected. These include cachexia, sarcopenia, osteoporosis, and various deconditioned states associated with an array of chronic illnesses.
New paradigms of therapeutic interventions can be realized from a systems approach and from the use of crossover therapies. The skeletal system is intensively involved with immunological and hormonal activity, and tapping these resources may provide more effective ways to manage disease.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please click <a href="company website
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (<a href="company website Members of the New York Academy of Science receive full–text access to the Annals online and discounts on print volumes. Please visit <a href="company website for more information about becoming a member.